Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Clinical trial NCT00633789 · COMPLETED

Trial details

NCT number: NCT00633789
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer Transitional Cell Carcinoma Soft Tissue Sarcoma Gastric/Esophageal Adenocarcinoma Pancreatic Cancer Including Ampulla of Vater

Start date: 2008-06-01
Primary completion: 2012-02-01
Enrollment: 597

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.